SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-09-133213
Filing Date
2009-06-18
Accepted
2009-06-18 16:26:45
Documents
7
Period of Report
2009-06-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 25799
2 FORM OF 9.125% SENIOR SECURED NOTES DUE 2017 dex41.htm EX-4.1 77915
3 INDENTURE dex42.htm EX-4.2 619866
4 REGISTRATION RIGHTS AGREEMENT dex43.htm EX-4.3 191992
5 AMENDMENT NO. 7 TO THE CREDIT AGREEMENT dex101.htm EX-10.1 29687
6 PRESS RELEASE dex991.htm EX-99.1 5824
7 GRAPHIC g39857g77e69.jpg GRAPHIC 6209
  Complete submission text file 0001193125-09-133213.txt   962191
Mailing Address
Business Address 16825 NORTHCHASE DR STE 1300 HOUSTON TX 77060 2818732674
US ONCOLOGY INC (Filer) CIK: 0000943061 (see all company filings)

IRS No.: 841213501 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26190 | Film No.: 09898997
SIC: 8093 Services-Specialty Outpatient Facilities, NEC

Mailing Address 16825 NORTHCHASE DRIVE, SUITE 1300 HOUSTON TX 77060
Business Address 16825 NORTHCHASE DRIVE, SUITE 1300 HOUSTON TX 77060 (832) 601-8766
US Oncology Holdings, Inc. (Filer) CIK: 0001333191 (see all company filings)

IRS No.: 200873619 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 333-126922 | Film No.: 09898999
SIC: 8060 Services-Hospitals